-
Je něco špatně v tomto záznamu ?
IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications
A. Vardi, A. Agathangelidis, LA. Sutton, M. Chatzouli, L. Scarfò, L. Mansouri, V. Douka, A. Anagnostopoulos, N. Darzentas, R. Rosenquist, P. Ghia, C. Belessi, K. Stamatopoulos,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1995 do Před 1 rokem
Freely Accessible Science Journals
od 1995
Open Access Digital Library
od 1995-01-01
Open Access Digital Library
od 1995-01-01
- MeSH
- chronická lymfatická leukemie genetika imunologie MeSH
- dospělí MeSH
- genová přestavba B-lymfocytů MeSH
- imunogenetika MeSH
- imunoglobulin D genetika MeSH
- imunoglobulin G genetika MeSH
- imunoglobulin M genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- receptory antigenů B-buněk klasifikace genetika MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- somatická hypermutace imunoglobulinových genů MeSH
- těžké řetězce imunoglobulinů genetika MeSH
- variabilní oblast imunoglobulinu genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
PURPOSE: Immunoglobulin G-switched chronic lymphocytic leukemia (G-CLL) is a rare variant of CLL, whose origin and ontogenetic relationship to the common IgM/IgD (MD-CLL) variant remains undefined. Here, we sought for clues about the ontogeny of G-CLL versus MD-CLL by profiling the relevant IG gene repertoires. EXPERIMENTAL DESIGN: Using purpose-built bioinformatics methods, we performed detailed immunogenetic profiling of a multinational CLL cohort comprising 1,256 cases, of which 1,087 and 169 expressed IG mu/delta and gamma heavy chains, respectively. RESULTS: G-CLL has a highly skewed IG gene repertoire that is distinct from MD-CLL, especially in terms of (i) overuse of the IGHV4-34 and IGHV4-39 genes and (ii) differential somatic hypermutation (SHM) load. Repertoire differences were also found when comparing subgroups with similar SHM status and were mainly attributed to the exclusive representation in G-CLL of two major subsets with quasi-identical (stereotyped) B-cell receptors. These subsets, namely #4 (IGHV4-34/IGKV2-30) and #8 (IGHV4-39/IGKV1(D)-39), were found to display sharply contrasting SHM and clinical behavior. CONCLUSIONS: G-CLL exhibits an overall distinct immunogenetic signature from MD-CLL, prompting speculations about distinct ontogenetic derivation and/or immune triggering. The reasons underlying the differential regulation of SHM among G-CLL cases remain to be elucidated.
Authors' Affiliations Hematology Department and HCT Unit G Papanicolaou Hospital
Central European Institute of Technology Masaryk University Brno Czech Republic
Department of Immunology Genetics and Pathology Uppsala University Uppsala Sweden
Division of Molecular Oncology San Raffaele Scientific Institute Milan Italy
Hematology Department Nikea General Hospital Piraeus Greece
Institute of Applied Biosciences Centre for Research and Technology Hellas Thessaloniki Greece
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14074509
- 003
- CZ-PrNML
- 005
- 20141007120700.0
- 007
- ta
- 008
- 141006s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1158/1078-0432.CCR-13-1993 $2 doi
- 035 __
- $a (PubMed)24240110
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vardi, Anna $u Authors' Affiliations: Hematology Department and HCT Unit, G. Papanicolaou Hospital; Institute of Applied Biosciences, Centre for Research & Technology Hellas, Thessaloniki, Greece; Division of Molecular Oncology, San Raffaele Scientific Institute, Milan, Italy; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Hematology Department, Nikea General Hospital, Piraeus, Greece; and Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
- 245 10
- $a IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implications / $c A. Vardi, A. Agathangelidis, LA. Sutton, M. Chatzouli, L. Scarfò, L. Mansouri, V. Douka, A. Anagnostopoulos, N. Darzentas, R. Rosenquist, P. Ghia, C. Belessi, K. Stamatopoulos,
- 520 9_
- $a PURPOSE: Immunoglobulin G-switched chronic lymphocytic leukemia (G-CLL) is a rare variant of CLL, whose origin and ontogenetic relationship to the common IgM/IgD (MD-CLL) variant remains undefined. Here, we sought for clues about the ontogeny of G-CLL versus MD-CLL by profiling the relevant IG gene repertoires. EXPERIMENTAL DESIGN: Using purpose-built bioinformatics methods, we performed detailed immunogenetic profiling of a multinational CLL cohort comprising 1,256 cases, of which 1,087 and 169 expressed IG mu/delta and gamma heavy chains, respectively. RESULTS: G-CLL has a highly skewed IG gene repertoire that is distinct from MD-CLL, especially in terms of (i) overuse of the IGHV4-34 and IGHV4-39 genes and (ii) differential somatic hypermutation (SHM) load. Repertoire differences were also found when comparing subgroups with similar SHM status and were mainly attributed to the exclusive representation in G-CLL of two major subsets with quasi-identical (stereotyped) B-cell receptors. These subsets, namely #4 (IGHV4-34/IGKV2-30) and #8 (IGHV4-39/IGKV1(D)-39), were found to display sharply contrasting SHM and clinical behavior. CONCLUSIONS: G-CLL exhibits an overall distinct immunogenetic signature from MD-CLL, prompting speculations about distinct ontogenetic derivation and/or immune triggering. The reasons underlying the differential regulation of SHM among G-CLL cases remain to be elucidated.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genová přestavba B-lymfocytů $7 D015322
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunogenetika $7 D007125
- 650 _2
- $a imunoglobulin D $x genetika $7 D007072
- 650 _2
- $a imunoglobulin G $x genetika $7 D007074
- 650 _2
- $a těžké řetězce imunoglobulinů $x genetika $7 D007143
- 650 _2
- $a imunoglobulin M $x genetika $7 D007075
- 650 _2
- $a variabilní oblast imunoglobulinu $x genetika $7 D007135
- 650 _2
- $a chronická lymfatická leukemie $x genetika $x imunologie $7 D015451
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a receptory antigenů B-buněk $x klasifikace $x genetika $7 D011947
- 650 _2
- $a somatická hypermutace imunoglobulinových genů $7 D027041
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Agathangelidis, Andreas $7 gn_A_00002103
- 700 1_
- $a Sutton, Lesley-Ann
- 700 1_
- $a Chatzouli, Maria
- 700 1_
- $a Scarfò, Lydia
- 700 1_
- $a Mansouri, Larry
- 700 1_
- $a Douka, Vassiliki
- 700 1_
- $a Anagnostopoulos, Achilles $7 gn_A_00005807
- 700 1_
- $a Darzentas, Nikos
- 700 1_
- $a Rosenquist, Richard
- 700 1_
- $a Ghia, Paolo
- 700 1_
- $a Belessi, Chrysoula
- 700 1_
- $a Stamatopoulos, Kostas
- 773 0_
- $w MED00001121 $t Clinical cancer research : an official journal of the American Association for Cancer Research $x 1078-0432 $g Roč. 20, č. 2 (2014), s. 323-30
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24240110 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20141006 $b ABA008
- 991 __
- $a 20141007121137 $b ABA008
- 999 __
- $a ok $b bmc $g 1042392 $s 873421
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 20 $c 2 $d 323-30 $i 1078-0432 $m Clinical cancer research $n Clin Cancer Res $x MED00001121
- LZP __
- $a Pubmed-20141006